Provided herein are pyrrolotriazine compounds for treatment of JAK kinase, including JAK2 kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
本文提供了用于治疗JAK激酶,包括JAK2激酶介导的疾病的
吡咯并三嗪化合物。还提供了包含该化合物的药物组合物和使用该化合物和组合物的方法。